Basal serum pancreatic polypeptide is dependent on age and gender in an adult population

References

• Villanueva M L, Hedo J A, Marco J. Fluctuations of pancreatic polypeptide in plasma: Effect of normal food ingestion and fasting. Proc Soc Exp Biol Med 1978; 159: 245–8
   PubMed Web of Science ®Google Scholar
• Langstein H N, Norton J A, Chiang H-CV, O'Dorisio T M, Maton P N, Marx S J, et al. The utility of circulating levels of human pancreatic polypeptide as a marker for islet cell tumors. Surgery 1990; 108: 1109–16
   PubMed Web of Science ®Google Scholar
• Howard T, Sawicki JM, Lewin K J, Steel Bhagavan BBS, Cummings O W, et al. Pancreatic polypeptide immunoreactivity in sporadic gastrinoma: relationship to intraabdominal location. Pancreas 1995; 11: 350–6
   PubMed Web of Science ®Google Scholar
• Bruckner H, Chesser WM, Mandeli RJ, Farber L, Di A, Giovanni G. Circulating pancreatic polypeptide in patients with adenocarcinoma of the bile duct. Acta Oncol 1993; 32: 627–9
   PubMed Web of Science ®Google Scholar
• Diem P, Redmon J, Abid B, Moran M., Sutherland AD, Halter EJB., et al. Glucagon, catecholamine and pancreatic polypeptide secretion in type I diabetic recipients of pancreas allografts. J Clin Invest 1990; 86: 2008–13
   PubMed Web of Science ®Google Scholar
• Gupta V, Wahoff D, Rooney CD, Poitout P, Sutherland VD, Kendall EDM., et al. The defective glucagon response from transplanted intrahepatic pancreatic islets during hypoglycemia is transplantation site-determined. Diabetes 1997; 46: 28–33
   PubMed Web of Science ®Google Scholar
• Landgraf Nusser RJ, Riepl R L, Fiedler F, Illner W D, Abendroth D., et al. Metabolic and hormonal studies of type-1 (insulin-dependent) diabetic patients after successful pancreas and kidney transplantation. Diabetologia 1991; 34: S61–S67, Suppfl
   PubMedGoogle Scholar
• van der Burg M, Guicherit PO, Jansen RJ, Frolich B, Lamers MCB, Lemkes HH, et al. Function and survival of intrasplenic islet autografts in dogs. Diabetologia 1996; 39: 37–44
   PubMed Web of Science ®Google Scholar
• Pyzdrowski K, Kendall LDM, Halter J B, Nakhleh R, Sutherland ED, Robertson ERP. Preserved insulin secretion and insulin independence in recipients of islet autografts [see comments]. N Engl J Med 1992; 327: 220–6
   PubMed Web of Science ®Google Scholar
• Rasmussen M, Carstensen HH, List S, Schwartz T, Hilsted WJ. Impaired pancreatic polypeptide response to a meal in type 1 diabetic patients: vagal neuropathv or islet cell dysfunction?. Acta Endocrinol 1995; 128: 221–4
   Google Scholar
• Kennedy FP, Go V LW, Cryer P E, Bolli G, Gerich BJE. Subnormal pancreatic polypeptide and epinephrine responses to insulin-induced hypoglycemia identify patients with insulin-dependent diabetes mellitus predisposed to develop overt autonomic neuropathy. Ann Intern Med 1995; 108: 54–8
   Google Scholar
• Carrá M, Brambilla P, Meschi Mistura FL, Bognetti E, Malesci A., et al. Pancreatic polypeptide secretion after insulin infusion and protein meal in juvenile type 1 diabetic subjects. Acta Diabetol Lat 1990; 27: 165–71
   PubMedGoogle Scholar
• Rattarasan Dagogo- C, Jack Zachwieja S, Cryer JPE. Hypoglycemia-induced autonomic failure in IDDM is specific for stimulus of hypoglycemia and is not attributable to prior autonomic activation. Diabetes 1994; 43: 809–18
   PubMed Web of Science ®Google Scholar
• Ryder R E, Owens DR, Hayes T M, Ghatei M, Bloom ASR. Unawareness of hypoglycaemia and inadequate hypoglycaemic counterregulation: no causal relation with diabetic autonomic neuropathy [see comments]. BMJ 1990; 301: 783–87
   PubMedGoogle Scholar
• Dagogo Jack S, Craft E, Cryer SPE. Hypo-glycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to. symptoms of, and defense against subsequent hypoglycemia. J Clin Invest 1993; 91: 819–28
   PubMed Web of Science ®Google Scholar
• Berger Crowther DRC, Floyd J C, Jr., Pek Fajans SSS. Effect of age on fasting plasma levels of pancreatic hormones in man. J Clin Endocrinol Metab 1978; 6: 1183–9
   Google Scholar
• Track N S, Watters L, Gauldie MJ. Motilin, Human pancreatic polypeptide (HPP) and gastrin plasma concentrations in fasting subjects. Clin Biochem 1979; 12: 109–17
   PubMed Web of Science ®Google Scholar
• Hanukoglu A, Kowarski A A, Chalew S. Human pancreatic polypeptide in children and young adults. Horm Metab Res 1990; 22: 41–3
   PubMed Web of Science ®Google Scholar
• Track N, Mc S, Leod R, Mee SAV. Human Pancreatic Polypeptide: studies of fasting and postprandial plasma concentrations. Can J Physiol Pharmacol 1980; 58: 1484–9
   PubMed Web of Science ®Google Scholar
• O'Hare M MT, Daly J G, Buchanan KD. Radioimmunoassay for pancreatic polypeptide, and its age-related changes in concentrations. Clin Chem 1983; 29: 1923–7
   PubMed Web of Science ®Google Scholar
• Floyd JC, Jr, Fajans SS. A newly recognized human pancreatic islet polypeptide: concentrations in healthy subjects and in patients with diabetes mellitus [Abstract]. Diabetes 1976; 25: 330
   Web of Science ®Google Scholar
• Floyd J C, Jr., Chance R E, Hayashi M, Moon N E, Fajans SS. Concentrations of a newly recognized pancreatic islet polypeptide in plasma of healthy subjects and in plasma and tumors of patients with insulin-secreting islet tumors. Clin Res 1975; 23: 535A
   Google Scholar
• Taylor I, Rotter LJ, Walsh JH, Passaro EJ. Is pancreatic polypeptide a marker for Zollinger-Ellingsons syndrome. Lancet 1978; 845–8
   PubMedGoogle Scholar
• Schwartz T, Stenquist WL, Stadil OF. Synchronous oscillations in the basal secretion of pancreatic-polypeptide concentrations in plasma. Gastroenterology 1979; 76: 14–9
   PubMed Web of Science ®Google Scholar
• Floyd JC., jr., Fajans S, Pek S, Chance SRE. A newly recognized pancreatic polypeptide; plasma levels in health and disease. Recent Prog Horm Res 1977; 33: 519–70
   Google Scholar
• Track N, Watters SL, Gauldie MJ. Human pancreatic polypeptide (HPP) plasma concentrations in fasting human infants and adults [Abstract]. Diabetologia 1978; 15: 276–7
   Web of Science ®Google Scholar
• Rasmussen B, Jensen K, Schroll RM, Olesen J. Epidemiology of headache in a general population-a prevalence studv. J Clin Epidemiol 1991; 44: 1147–57
   PubMed Web of Science ®Google Scholar
• Schwartz T, Hoist WJ, Fahrenkrug JJ, Jensen S L, Nielsen O V, Rehfeld J F, et al. Vagal, cholinergic regulation of pancreatic polvpeptide secretion. J Clin Invest 1978; 61: 781–9
   PubMed Web of Science ®Google Scholar
• Ekins R, Newman B. Endocrinol 1970; 147: 11–36, Suppl
   Google Scholar
• Gingerich R, Nagulesparan L, Bennion ML, Dye E S, Bauman WA. Pancreatic polypeptide in Pima Indians: The influence of obesity and diabetes. Metabolism 1985; 34: 25–9
   PubMed Web of Science ®Google Scholar
• Tsuda K, Seino Y, Mori K, Seino S, Takemura J, Kuzuya H, et al. Hyperfunction of the entero-PP axis in non-insulin dependent diabetes mellitus. Horm Metab Res 1983; 15: 581–5
   PubMed Web of Science ®Google Scholar
• Marco J, Zulueta M A, Correas I, Villanueva ML. Reduced pancreatic polypeptide secretion in obese subjects. J Clin Endocrinol Metab 1980; 50: 744–7
   PubMed Web of Science ®Google Scholar
• Lassmann V, Vague P, Vialettes B, Simon M. Low plasma levels of pancreatic polypeptide in obesity. Diabetes 1980; 29: 428–30
   PubMed Web of Science ®Google Scholar
• Lieverse R J, Masclee A AM, Jansen J BMJ, Lamers C BHW. Plasma cholecystokinin and pancreatic polypeptide secretion in response to bombesin, meal, ingestion and modified sham-feeding in lean and obese persons. Int J Obesity 1994; 18: 123–7
   PubMed Web of Science ®Google Scholar
• Zipf W BO, Dorisio T M, Catland S, Sotos J. Blunted pancreatic polypeptide response in children with obesity of Prader-Willi syndrome. J Clin Endocrinol Metab 1981; 52: 1264–6
   PubMed Web of Science ®Google Scholar
• Holst J J, Schwartz T W, Lovgreen N A, Pedersen O, Beck-Nielsen H. Diurnal profile of pancreatic polypeptide, pancreatic glucagon, gut glucagon and insulin in human morbid obesity. Int J Obesity 1982; 7: 529–38
   Web of Science ®Google Scholar
• Boden G, Master R W, Owen O E, Rudnick MR. Human pancreatic polypeptide in chronic renal failure and cirrhosis of the liver; role of the kidneys and liver in pancreatic polypeptide metabolism. J Clin Endocrinol Metab 1980; 51: 573–8
   PubMed Web of Science ®Google Scholar
• Hagopian W, Lever E G, Cohen D, Emmanouel D, Polonsky K S, Pugh W, et al. Predominance of renal and absence of hepatic metabolism of pancreatic polypeptide in the dog. Am J Physiol 1983; 245: E171–E177
   Google Scholar
• Shulkes A, Bijaphala S, Dawborn J K, Fletcher D R, Hardy KJ. Metabolism of neurotensin and pancreatic polypeptide in man: role of the kidney and plasma factors. J Clin Endocrinol Metab 1984; 58: 873–9
   PubMed Web of Science ®Google Scholar
• Henriksen J H, Schwartz T W, Bülow JB. Endogenous pancreatic polypeptide in different vascular beds: relationship to release and degradation in subjects with normal and decreased kidney function. Metabolism 1986; 35: 542–6
   PubMed Web of Science ®Google Scholar
• Ishida T, Chou M C, Chou J, Lewis R M, Hartley C J, Entman M, et al. Absence of hepatic extraction of pancreatic polypeptide in conscious dogs. Am J Physiol 1983; 245: E401–E409
   Google Scholar